Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Nkarta Inc
(NQ:
NKTX
)
6.370
+0.020 (+0.31%)
Streaming Delayed Price
Updated: 11:19 AM EDT, Jul 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nkarta Inc
< Previous
1
2
3
4
5
Next >
The Latest Analyst Ratings for Nkarta
August 10, 2023
Via
Benzinga
Nkarta Reports Second Quarter 2023 Financial Results and Corporate Highlights
August 10, 2023
From
Nkarta, Inc.
Via
GlobeNewswire
3 Hidden Penny Stocks That Could Turn $100 into $10,000
July 31, 2023
These penny stocks have multibagger upside potential with great margins of safety, according to Wall Street analysts.
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
July 05, 2023
Wednesday's session saw 43 companies set new 52-week lows.
Via
Benzinga
Analyst Expectations for Nkarta's Future
June 27, 2023
Via
Benzinga
NKX101's Leukemia Setting Phase 1 Results a Setback for Nkarta: Analyst Lowers Price Target Amid Revised Development Timeline
June 27, 2023
Nkarta Inc (NASDAQ: NKTX) announced updated data from the Phase 1 study of NKX101 to treat patients with relapsed or refractory (r/r)
Via
Benzinga
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 27, 2023
Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 27, 2023
Via
Benzinga
Nkarta's Updated Data From Leukemia Study Fails To Cheer Investors
June 27, 2023
Nkarta Inc (NASDAQ: NKTX) announced updated data from the Phase 1 study of NKX101 to treat patients with relapsed or refractory (r/r)
Via
Benzinga
Why Shares of Nkarta Are Slumping Tuesday
June 27, 2023
The pharmaceutical stock dropped after announcing so-so clinical trial results.
Via
The Motley Fool
Nkarta Updates Clinical Progress of CAR-NK Cell Therapy NKX101 for Patients with Relapsed or Refractory Acute Myeloid Leukemia
June 27, 2023
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta to Host Conference Call to Discuss Updated Clinical Data from NKX101 NK Cell Therapy Program
June 26, 2023
Call scheduled for Tuesday, June 27, 2023 at 8:00 a.m. ET
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta Presents NKX019 Clinical Data at the European Hematology Association 2023 Congress and 17th International Conference on Malignant Lymphoma
June 10, 2023
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta Reports First Quarter 2023 Financial Results and Corporate Highlights
May 11, 2023
From
Nkarta, Inc.
Via
GlobeNewswire
7 Stocks With Promising Upside Potential for 100% Returns
May 07, 2023
If you still want to gamble even during this market environment, these are the stocks with 100% upside potential.
Via
InvestorPlace
Nkarta Presents Preclinical Data Exploring Gene Knockout Strategies and Combination Agents with NK Cell-Based Therapies at the 2023 AACR Annual Meeting
April 17, 2023
From
Nkarta, Inc.
Via
GlobeNewswire
3 Biotech Stocks to Watch for Potential Breakthroughs
April 11, 2023
These biotech stocks have significant upside and realistic breakthrough chances in the current and distant future.
Via
InvestorPlace
NVIDIA To Rally Around 19%? Here Are 10 Other Analyst Forecasts For Friday
March 17, 2023
Wells Fargo raised the price target for Warner Bros. Discovery, Inc. (NASDAQ: WBD) from $13 to $20. Wells Fargo analyst Steven Cahall upgraded the stock from Equal-Weight to Overweight. Warner Bros....
Via
Benzinga
Nkarta Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights
March 16, 2023
From
Nkarta, Inc.
Via
GlobeNewswire
EXCLUSIVE: Top 10 Searched Tickers On Benzinga Pro In December 2022: Where Do Tesla, Apple, AMC Rank?
January 03, 2023
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022
December 22, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 08, 2022
During Thursday's trading, 138 companies set new 52-week lows.
Via
Benzinga
What's Next For Cell Therapy In Oncology? Enlivex (NASDAQ: ENLV) Says It Has The Answers
December 06, 2022
Since Robert Hooke discovered cells in 1665 and Theodor Schwann proposed the classical cell theory in 1839, the cell therapy industry has grown by leaps and bounds.
Via
TheNewswire.com
What's Next For Cell Therapy In Oncology? Enlivex (NASDAQ: ENLV) Says It Has The Answers
December 06, 2022
By Ernest Dela Aglanu, Benzinga
Via
News Direct
VF Corp, Verve Therapeutics And Some Other Big Stocks Moving Lower On Monday
December 05, 2022
U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Why Nkarta Stock (NKTX) Is Volatile During Monday's Session?
December 05, 2022
Nkarta Inc (NASDAQ: NKTX) shares are trading lower by 5.82% to $8.09, reversing after trading higher during the pre-market session, after the company announced updated data from its Phase 1 dose...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
December 05, 2022
The biggest pre-market stock movers for Monday include many Chinese shares that traders will want to keep an eye on today!
Via
InvestorPlace
Nkarta Announces Updated Clinical Data on Anti-CD19 Allogeneic CAR-NK Cell Therapy NKX019 for Patients with Relapsed or Refractory Non-Hodgkin Lymphoma
December 05, 2022
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta Reports Third Quarter 2022 Financial Results and Corporate Highlights
November 09, 2022
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta Presents Data Supporting Engineered NK Cell Based Combination Therapies and Next Generation Commercial-Scale Manufacturing Platform at SITC 37th Annual Meeting
November 07, 2022
From
Nkarta, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.